These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8821899)
21. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A J Clin Endocrinol Metab; 2003 Mar; 88(3):1389-93. PubMed ID: 12629134 [TBL] [Abstract][Full Text] [Related]
22. Protein anabolic action of insulin, growth hormone and insulin-like growth factor I. Russell-Jones DL; Umpleby M Eur J Endocrinol; 1996 Dec; 135(6):631-42. PubMed ID: 9025701 [No Abstract] [Full Text] [Related]
23. The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus. Cheetham TD; Jones J; Taylor AM; Holly J; Matthews DR; Dunger DB Diabetologia; 1993 Jul; 36(7):678-81. PubMed ID: 8359587 [TBL] [Abstract][Full Text] [Related]
34. Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Cummings EA; Sochett EB; Dekker MG; Lawson ML; Daneman D Diabetes; 1998 Aug; 47(8):1341-6. PubMed ID: 9703337 [TBL] [Abstract][Full Text] [Related]
35. Insulin therapy in the last decade. A pediatric perspective. Santiago JV Diabetes Care; 1993 Dec; 16 Suppl 3():143-54. PubMed ID: 8299471 [No Abstract] [Full Text] [Related]
36. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191 [TBL] [Abstract][Full Text] [Related]
37. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion. Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388 [TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus. Dunger DB; Cheetham TD; Crowne EC Metabolism; 1995 Oct; 44(10 Suppl 4):119-23. PubMed ID: 7476304 [TBL] [Abstract][Full Text] [Related]
39. Frailty and the somatopause. Martin F Growth Horm IGF Res; 1999 Feb; 9(1):3-10. PubMed ID: 10207502 [No Abstract] [Full Text] [Related]
40. Metabolic impact of puberty on the course of type 1 diabetes. Acerini CL; Williams RM; Dunger DB Diabetes Metab; 2001 Sep; 27(4 Pt 2):S19-25. PubMed ID: 11787432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]